Boehringer Ingelheim International Gmbh

Bayer Intellectual Property Gmbh

Other

Bayer Pharma Aktiengesellschaft

Bayer Healthcare Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Bayer Schering Pharma Ag

Aicuris Anti-infective Cures Gmbh

Aicuris Gmbh & Co. Kg

Dagmar Karthaus

Adrian Tersteegen

Martin Hendrix

Lars Bärfacker

Heike Heckroth

Daniel Meibom

Volkhart Min-Jian Li

Klemens Lustig

Martina Delbeck

Franz Von Nussbaum

Marja Van Kampen

Frank-Thorsten Hafner

Sonja Anlauf

Franz-Josef Van Der Staay

Christina Erb

Jens Schamberger

Karl-Heinz Schlemmer

Dieter Lang

Jörg Keldenich

Dirk Schneider

Maria Niewöhner, Legal Representative

Hilmar Bischoff

Rudolf Schohe-Loop

Joachim Schuhmacher

Peter Kolkhof

Carsten Schmeck

Bernd Riedl

Heinrich Meier

Tobias Wunberg

Kerstin Henninger

Elisabeth Pook

Ingo Flamme

Holger Zimmermann

Ulrich Ebert

Cristina Alonso-Alija

Chantal Fürstner

Mary F Fitzgerald

Nils Burkhardt

Frank Mauler

Heike Gielen-Haertwig

Ulf Brüggemeier

Niels Svenstrup

Graham Sturton

Nigel J Cuthbert

Daniela Paulsen

Arno Friedl

Dirk Heimbach

Eckhard Bender

Volker Geiss

Martina Klein

Irene Gerlach

Özkan Yalkinoglu

Volker Hinz

Martin Michels

Bettina Beyreuther

Lars Baerfacker

Verena Voehringer

David Brückner

Andreas Goeller

Yan-Hong Liu

Christine Erb

The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD

The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof

4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use

The invention relates to 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation, and their use for producing medicaments for improving learning and/or memory. The 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines are of the formula (I): with the variables as defined in the claims.

6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines

The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.

6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines

The present application relates to novel sulfonamide- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof

The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory. The pyrazolopyrimidine compounds are within the formula (I) 

The present invention relates to novel 1,4-diarylpyrimido[4,5-d]pyridazine-2,5-dione derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

1,4-diaryl-pyrimidopyridazine-2,5-diones and their use

The invention relates to novel cyanopyrimidinones, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.

Cyanopyrimidinones

The invention relates to substituted arylsulfonamides of formula (I) and methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses. 

Substituted arylsulfonamides as antiviral agents

The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.

Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

Described are 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolo[3,4-d]pyrimidines of the formula (I): as defined herein, processes for their preparation and their use for producing medicaments for treating impairment of perception, concentration, learning and/or memory.

6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory

Growing community of inventors

Solingen, Germany

Dagmar Karthaus